YOLK

Yolk is an emerging biotechnology company focused on the discovery and development of novel therapeutic modalities for high-unmet-need areas, particularly in oncology and metabolic disorders. The company leverages a proprietary discovery platform designed to identify and optimize bioactive molecules with enhanced pharmacological profiles. By integrating advanced computational modeling with high-throughput screening, Yolk aims to accelerate the transition of early-stage candidates into clinical development. Their current pipeline is primarily in the pre-clinical phase, targeting specific molecular pathways that have historically been difficult to modulate.